THERAPIE D'INDUCTION PAR RITUXIMAB SUIVIE D'UNE THERAPIE PAR ACETATE DE GLATIRAMERE

• 收藏
• 分享

专利权人:

TEVA PHARMACEUTICAL INDUSTRIES LTD.

发明人:

VOLLMER, TIMOTHY

申请号：

CA2903127

公开号：

CA2903127A1

申请日:

2014.03.12

申请国别(地区):

CA

年份:

2014

代理人:

摘要：

The present invention provides a method of treating a subject afflicted with a form of multiple sclerosis or presenting a clinically isolated syndrome comprising periodic administration of an amount of an anti-CD20 antibody at least twice to the subject followed by periodic administration of an amount of glatiramer acetate to the subject, wherein the amounts are effective to treat the subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/